Metabolon
Metabolomic Profiling Diagnoses Inborn Errors of Metabolism at Higher Rate Than Traditional Approach
In a cross-sectional study, metabolomic profiling had an overall diagnostic rate of 7.1 percent, a Baylor College of Medicine-led team found.
Metabolon Strikes Biomarker Discovery Partnership With Cleveland Clinic
The deal centers around Metabolon's platform for identifying pharmacodynamic, efficacy, and response biomarkers and tracking changes in biological pathways.
Metabolon Closes $72M in Debt and Equity Funding
The firm said it would use the funding to grow its client base and further R&D programs using machine learning for biomarker discovery and precision medicine.
Metabolon, Merck KGaA Form Metabolomics Alliance
Metabolon's Precision Metabolomics platform identifies pharmacodynamic, efficacy, and response biomarkers and tracks changes in biological pathways.
Metabolon Inks Deal to Perform Metabolomic Profiling for VA
The company will provide the services for the VA's Million Veteran Program, which is studying the link between genes and disease in US veteran volunteers.